Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01768624Completed

PINOT Follow-up Study in End-stage Kidney Disease

Role: collaborator

NCT02128412Not ApplicableUnknown

IVUS Controlled Stenting

Role: lead

NCT01298115Completed

Patient INformation About Options for Treatment - PINOT

Role: collaborator

NCT00114439Phase 2Completed

Lithium Cannabis Withdrawal Study

Role: lead

NCT00251108Not ApplicableCompleted

Fitness Training After Traumatic Brain Injury

Role: lead

NCT00124033Not ApplicableTerminated

Management of Common Bile Duct (CBD) Stones at Laparoscopic Cholecystectomy

Role: collaborator

NCT00127725Phase 2Unknown

Pulsed Electromagnetic Field (PEMF) Stimulation for Tibia Fractures

Role: lead

NCT00120601Phase 4Unknown

Trial for the Treatment of Alcohol Dependence

Role: collaborator

All 8 trials loaded